CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

INF39 25mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

INF39 2mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

INF39 50mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

INF39 5mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

INF39 10mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

Ingenol 10mg  | ≥99%

CSNpharm

Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity.

More Information Supplier Page

Ingenol 25mg  | ≥99%

CSNpharm

Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity.

More Information Supplier Page

Ingenol 1mg  | ≥99%

CSNpharm

Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity.

More Information Supplier Page

Ingenol 50mg  | ≥99%

CSNpharm

Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity.

More Information Supplier Page

Ingenol 5mg  | ≥99%

CSNpharm

Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity.

More Information Supplier Page

INO-1001 250mg  | ≥99%

CSNpharm

INO-1001 is a potent inhibitor of PARP with IC50 of < 50 nM in CHO cells and a mediator of oxidant-induced myocyte dysfunction during reperfusion.

More Information Supplier Page

INO-1001 50mg  | ≥99%

CSNpharm

INO-1001 is a potent inhibitor of PARP with IC50 of < 50 nM in CHO cells and a mediator of oxidant-induced myocyte dysfunction during reperfusion.

More Information Supplier Page

Inosine 5g  | ≥99%

CSNpharm

Inosine is an endogenous purine nucleoside with immunomodulatory, neuroprotective, and analgesic properties.

More Information Supplier Page

IOX1 10mg  | ≥99%

CSNpharm

IOX1 is the broad-spectrum inhibitor of 2OG oxygenases and its IC50 for KDM4A/KDM3A and KDM4C/KDM6B/KDM2A/KDM4E are 0.6/0.1 μM and 0.6 μM/1.6 μM/1.8 μM/2.3 μM.

More Information Supplier Page

IOX1 1mg  | ≥99%

CSNpharm

IOX1 is the broad-spectrum inhibitor of 2OG oxygenases and its IC50 for KDM4A/KDM3A and KDM4C/KDM6B/KDM2A/KDM4E are 0.6/0.1 μM and 0.6 μM/1.6 μM/1.8 μM/2.3 μM.

More Information Supplier Page

IOX1 5mg  | ≥99%

CSNpharm

IOX1 is the broad-spectrum inhibitor of 2OG oxygenases and its IC50 for KDM4A/KDM3A and KDM4C/KDM6B/KDM2A/KDM4E are 0.6/0.1 μM and 0.6 μM/1.6 μM/1.8 μM/2.3 μM.

More Information Supplier Page

IOX1 50mg  | ≥99%

CSNpharm

IOX1 is the broad-spectrum inhibitor of 2OG oxygenases and its IC50 for KDM4A/KDM3A and KDM4C/KDM6B/KDM2A/KDM4E are 0.6/0.1 μM and 0.6 μM/1.6 μM/1.8 μM/2.3 μM.

More Information Supplier Page

IPA-3 50mg  | ≥98%

CSNpharm

IPA-3 is a selective non-ATP competitive PAK1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6).

More Information Supplier Page

IPA-3 5mg  | ≥98%

CSNpharm

IPA-3 is a selective non-ATP competitive PAK1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6).

More Information Supplier Page

IPA-3 10mg  | ≥98%

CSNpharm

IPA-3 is a selective non-ATP competitive PAK1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6).

More Information Supplier Page